Commencement of National CME Series at Isra University, Hyderabad
CME activities vital to keep the medical community abreast of the recent advancements: Dr A G Qazi
Hyderabad: CME activities are vital to keep the medical community abreast of the recent advancements, said Dr A G Qazi, Medical Director of Isra University Hospital, while speaking at the inaugural session of National CME Series at the hospital. The series, spanning over a year with twelve monthly sessions, is being conducted under the aegis of Clinical Excellence and Leadership Program (CELP) of Macter International.
Dr Muhammad Sadik Memon, Associate Professor and Head of the section of Gastroenterology and Hepatology, in his presentation on the topic of “What should I do when I see a patient with positive Anti HCV or HBsAg?”, advised the family physicians for proper history taking, examination of the patient with focus on stigmata of cirrhosis, ultrasound of abdomen to rule out decompensation, testing and vaccination of spouse and screening of the family members of the patient.
Sixty percent of HCV patients above 50 years of age develop cirrhosis: Dr Muhammad Sadik Memon
Dr Muhammad Aamir Ghauri, Assistant Professor, Isra University Hospital, discussed the topic of “How to Monitor Interferon Therapy for HCV patients?” with the help of various case studies.
Discussing about hepatitis B vaccination, Dr Fida Hussain Shaikh informed that Hepatitis B vaccine is a protein subunit type of vaccine, containing hepatitis B surface antigen (HBsAg) – an envelope protein of HBV. He informed that HBV vaccine generates protective (>10 IU/ml) levels of antibodies to HBsAg in 95% of children and 90% of adults. He advised that the whole population including HCV positive cases should be vaccinated after testing their HBsAg status on MEA, as HBV vaccine has good immunogenicity in immuno-competent persons.
Whole population including HCV positive cases should be vaccinated for Hepatitis B after testing their HBsAg status: Dr Fida Hussain Shaikh
Dr Syed Mujtaba Shah discussed about Gilbert Syndrome and Non-Alcoholic Fatty Liver Disease (NAFLD) in his presentation. He informed that Gilbert Syndrome is an autosomal recessive disorder characterized by intermittent jaundice in the absence of hemolysis or underlying liver disease. Regarding NAFLD, he stated that it is fatty inflammation of the liver when this is not due to excessive alcohol use and is related to insulin resistance and metabolic syndrome. He further stated that NAFLD may respond to treatments originally developed for other insulin resistant states.
